Polidocanol

From Self-sufficiency
Jump to: navigation, search
Polidocanol
250px
Systematic (IUPAC) name
2-[2-[2-[2-[2-[2-[2-[2-[2-(Dodecyloxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol
Identifiers
CAS Number 3055-99-0
ATC code C05BB02 (WHO)
PubChem CID 656641
Chemical data
Formula C30H62O10
Molar mass 582.81 g/mol[[Script error: No such module "String".]]
Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

Polidocanol is a sclerosant, an irritant injected to treat varicose veins.[1] Polidocanol causes fibrosis inside varicose veins, occluding the lumen of the vessel, and reducing the appearance of the varicosity. Current research is involved in development of polidocanol as a topical therapy, where systemic safety might no longer be an issue.

The FDA has approved Chemische Fabrik Kreussler & Co.’s Asclera (polidocanol) injection for the treatment of small varicose (less than 1 mm in diameter) and reticular veins (1 to 3 mm in diameter). Asclera works by damaging the cell lining of blood vessels, causing them to close and eventually be replaced by other types of tissue. [2]

Synonyms

  • Polydocanol
  • Laureth 9
  • Macrogol lauryl ether
  • Lauromacrogols
  • (mixed macrogols)
  • PEG-9 lauryl alcohol
  • POE-9 lauryl alcohol
  • Ethoxylated alcohols
  • Dodecylnonaoxyethylene glycol monoether
  • Dodecylpolyethyleneglycolether
  • Hydroxyl polyethoxy dodecane
  • Oxypolyethoxydodecane
  • Asclera[3]

References

Cite error: Invalid <references> tag; parameter "group" is allowed only.

Use <references />, or <references group="..." />
de:Polidocanol

nl:Polidocanol

pl:Polidokanol
  1. Sclerotherapy, Laurence Z Rosenberg, MD, eMedicine.com
  2. [1]
  3. "Asclera Full Prescribing Information in Drug Reference Encyclopedia". Retrieved 2010-04-11. .